DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,222,010 | +20.8% | 3,738,802 | +5.6% | 0.02% | +20.0% |
| Q2 2023 | $45,730,485 | +59.0% | 3,539,385 | +20.7% | 0.02% | +50.0% |
| Q1 2023 | $28,758,707 | +150785.1% | 2,931,727 | +63.7% | 0.01% | +66.7% |
| Q4 2022 | $19,060 | -99.8% | 1,791,380 | +138.5% | 0.01% | +100.0% |
| Q3 2022 | $7,840,000 | +2290.2% | 750,976 | +5265.3% | 0.00% | – |
| Q2 2015 | $328,000 | +0.3% | 13,997 | -4.0% | 0.00% | – |
| Q1 2015 | $327,000 | +165.9% | 14,581 | +99.6% | 0.00% | – |
| Q4 2014 | $123,000 | – | 7,305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
| Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
| PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
| Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
| FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
| Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
| GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |